Research Into Biomarkers Predictive of Survival and Response to Cancer Treatment (BEST)

Centre Antoine Lacassagne

Status: Enrolling

Conditions: Cancer

Treatments: Other: blood sampling

Study type: Interventional

Funder types: Other

Identifiers

NCT06851975

2018-61

Details and patient eligibility

About

Research into biomarkers predictive of survival and response to cancer treatment

Enrollment: 40,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient having a blood test, venous line insertion or injection on an implantable venous device scheduled as part of their standard care,
• Patient who has read the information note and stated that he/she has no objections
• Patient who has not objected to the use of this data for medical research purposes
• Patient with social security cover.

Exclusion criteria

• Patient already included in the study
• Patient considered to be a vulnerable person; vulnerable persons are defined in article L1121-5 to -8

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

40,000 participants in 1 patient group

principal

Other group

Description:

blood sampling

Treatment:

Other: blood sampling